Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-004543-24Phase 4Active
Phase 4, randomised, single-blind trial of polyethylene glycol + electrolytes + ascorbic acid and Selg Esse (2 arms), sponsored by Ospedale Fatebenefratelli. Primary endpoint: Adequate bowel cleansing non-inferiority. Started Nov 2020; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-004543-24.